Clinical review: Serious adverse events associated with the use of rituximab - a critical care perspective.
about
A Case of Interstitial Lung Disease Probably Related to Rituximab Treatment.Treatment strategy for reducing the risk of rituximab-induced cytokine release syndrome in patients with intravascular large B-cell lymphoma: a case report and review of the literature.Rituximab: modes of action, remaining dispute and future perspective.Therapeutic Application of Monoclonal Antibodies in Multiple Sclerosis.Safety Profile of Anticancer and Immune-Modulating Biotech Drugs Used in a Real World Setting in Campania Region (Italy): BIO-Cam Observational StudySuppression of rheumatoid arthritis B cells by XmAb5871, an anti-CD19 antibody that coengages B cell antigen receptor complex and Fcγ receptor IIb inhibitory receptor.
P2860
Clinical review: Serious adverse events associated with the use of rituximab - a critical care perspective.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Clinical review: Serious adver ...... - a critical care perspective.
@ast
Clinical review: Serious adver ...... - a critical care perspective.
@en
type
label
Clinical review: Serious adver ...... - a critical care perspective.
@ast
Clinical review: Serious adver ...... - a critical care perspective.
@en
prefLabel
Clinical review: Serious adver ...... - a critical care perspective.
@ast
Clinical review: Serious adver ...... - a critical care perspective.
@en
P2093
P2860
P921
P356
P1433
P1476
Clinical review: Serious adver ...... - a critical care perspective
@en
P2093
Chester V Oddis
Hrishikesh S Kulkarni
Hussein A Tawbi
P2860
P2888
P356
10.1186/CC11304
P577
2012-08-31T00:00:00Z
P5875
P6179
1029568329